How Are Healthcare CEOs Steering Through Uncertainty?
Exchanges18 Nov 2019

How Are Healthcare CEOs Steering Through Uncertainty?

Healthcare CEOs in the US are “trying to set course in an otherwise unpredictable, highly uncertain world,” according to this episode’s guest, Marshall Smith, global head of Goldman Sachs’ healthcare investment banking. The uncertainty, stemming from global growth concerns, trade policy risk and drug pricing debates, is a consistent theme across the healthcare industry, but that doesn’t mean corporations are sitting back and waiting. Growth strategies are top priorities for executives, Smith explains, with pharmaceutical companies turning to M&A–both to acquire smaller biotech companies for their drug portfolios and to merge with other large pharma companies. Smith also discusses how being the son of a doctor spurred an early interest in healthcare. “My dad would come home from the hospital [and] we’d have dinner together, all seven of us sitting around the table,” Smith recalled. “And so, invariably, we ended up talking about medical cases at dinner pretty much every night.” Learn more about your ad choices. Visit megaphone.fm/adchoices

Avsnitt(616)

Healthcare's Balance Between Science and Commerce

Healthcare's Balance Between Science and Commerce

Jami Rubin, business unit leader of the Healthcare Research Group for Goldman Sachs Research, discusses top trends in healthcare, including progress in the fight against cancer, diabetes and Alzheimer...

13 Juli 201619min

Brexit: After the Vote

Brexit: After the Vote

The UK's vote to leave the EU sets in motion a series of complex adjustments for the UK and Europe that will take years to play out. Huw Pill, chief European economist in Goldman Sachs Research, discu...

28 Juni 201628min

The Big Deal about Big Data

The Big Deal about Big Data

Armen Avanessians, chief investment officer of Goldman Sachs Asset Management's Quantitative Investment Strategies team, discusses how big data can help investors make smarter, better informed decisio...

16 Juni 201626min

Bright Spots in Emerging Markets

Bright Spots in Emerging Markets

A better external backdrop is just part of the reason why emerging market assets have surprised in the first half of 2016. Kamakshya Trivedi, chief Emerging Markets macro strategist in Goldman Sachs R...

3 Juni 201624min

Disruption in Deutschland

Disruption in Deutschland

Export-heavy Germany is contending with a wave of disruptive changes that are altering the competitive landscape for both the country's largest corporations and its globally admired small and medium-s...

19 Maj 201624min

Whenever, Wherever: The New Model for Retail

Whenever, Wherever: The New Model for Retail

Kathy Elsesser, global co-head of the Consumer Retail and Healthcare Group in the Investment Banking Division at Goldman Sachs discusses how the slowdown in deal-making in the first quarter of 2016 ha...

4 Maj 201616min

Niche No Longer: ESG Investing Goes Mainstream

Niche No Longer: ESG Investing Goes Mainstream

What does it mean to be an environmental, social and governance (ESG) investor? For John Goldstein, co-founder of Imprint Capital and a managing director in Goldman Sachs Asset Management, investing f...

21 Apr 201628min

Mutant Mosquitoes, 'Peak Stuff' and the Shifting Currents of Innovation

Mutant Mosquitoes, 'Peak Stuff' and the Shifting Currents of Innovation

Hugo Scott-Gall recaps the technologies and topics discussed at the second-annual Goldman Sachs Research Innovation Symposium, including the evolving markets for drones, the surprising demographics of...

6 Apr 201620min

Populärt inom Business & ekonomi

framgangspodden
varvet
rss-jossan-nina
rss-svart-marknad
svd-tech-brief
rss-borsens-finest
badfluence
uppgang-och-fall
avanzapodden
bathina-en-podcast
fill-or-kill
rss-inga-dumma-fragor-om-pengar
24fragor
lastbilspodden
rss-dagen-med-di
kapitalet-en-podd-om-ekonomi
tabberaset
rss-veckans-trade
rss-kort-lang-analyspodden-fran-di
borsmorgon